首页 > 市场调查报告书 > 食物/饮料

机能性食品

维生素K2市场规模、份额和成长分析（按功能、产品类型、形态、来源、应用和地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1899250

维生素K2市场规模、份额和成长分析（按功能、产品类型、形态、来源、应用和地区划分）－2026-2033年产业预测

Vitamin K2 Market Size, Share, and Growth Analysis, By Function (Bone and Cardiovascular Health, Blood Health and Clotting), By Product Type (MK-4, MK-7), By Form, By Source, By Application, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月26日 | 出版商:

SkyQuest | 英文 160 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，维生素 K2 市场规模将达到 1.8422 亿美元，到 2025 年将达到 2.0983 亿美元，到 2033 年将达到 5.9437 亿美元，在预测期（2026-2033 年）内复合年增长率为 13.9%。

维生素K2市场预计将迎来显着增长，这主要得益于消费者对其健康益处的认知不断提高、人口老龄化等人口趋势以及消费者对机能性食品日益增长的兴趣。维生素K2对心血管和骨骼健康的正面作用已得到公认，随着消费者更加重视慢性病预防和整体健康，对维生素K2补充剂的需求也随之增加。研究不断证实其治疗益处，进一步激发了人们对维生素K2的兴趣。此外，骨质疏鬆症和心血管疾病等日益严重的健康问题凸显了对高效能维生素K2产品的需求。这种必需营养素能够促进钙质沉积于骨骼，从而降低骨折风险，并且在降低心臟病和动脉钙化方面也展现出良好的效果，进一步推动了市场扩张。

维生素K2市场驱动因素

随着人们对维护骨骼健康重要性的认识不断提高，维生素K2市场正经历显着成长。公共卫生措施的加强和媒体的广泛报导凸显了维生素K2在骨骼矿化和预防骨质疏鬆症方面的作用，从而激发了消费者的关注。这种意识的提高导致需求显着增长，因为人们希望保持骨骼强健并降低骨折风险。加强对维生素K2促进骨骼密度益处的公共教育，鼓励了消费者的参与，并大大促进了市场的扩张。

维生素K2市场限制

由于优质维生素K2补充剂高成本，维生素K2市场面临严峻挑战。许多优质产品，尤其是采用高生物利用度形式（例如MK-7）配製的产品，定价较高，令注重成本的消费者难以负担。这种经济障碍可能导致潜在客户完全放弃维生素K2补充剂，或选择价格更低但功效可能不相上下的替代品。因此，消费者不愿投资购买优质产品阻碍了维生素K2的广泛普及和使用，在日益注重健康的市场环境下，限制了其整体市场成长潜力。

维生素K2市场趋势

维生素K2市场正经历显着成长，这主要得益于消费者对机能性食品日益增长的兴趣，这些食品不仅提供基本的营养补充，还能带来健康益处。随着注重健康的消费者寻求有助于提升整体健康的产品，製造商正积极将维生素K2添加到各种产品中，包括植物来源替代品、强化乳製品和营养点心棒。这一趋势反映了更广泛的健康意识提升趋势，随着消费者积极寻求有益于整体健康的成分，维生素K2市场正在不断扩大。因此，添加维生素K2的产品预计将会增加，从而吸引更多寻求营养选择的消费者。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲（MEA）
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争格局

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市集活动
主要企业市占率（2025 年）

主要企业简介

AlloSource（US）
Smith+Nephew（UK）
Medtronic（Ireland）
Orthofix US LLC（US）
Zimmer Biomet（US）
Geistlich Pharma AG（Switzerland）
Stryker（US）
Biobank（UK）
DSM Nutritional Products（Switzerland）
Pharmavit（India）
Viridis BioPharma Pvt. Ltd.（India）
Lactonova Nutripharm Pvt. Ltd.（India）
Gencor Pacific Inc.（US）
NuScience Trading, LLC（US）
NutriScience Innovations LLC（US）
ExcelVite Sdn. Bhd.（Malaysia）
Parchem Fine & Specialty Chemicals（US）
Avanscure Lifesciences Pvt. Ltd.（India）
Health Thru Nutrition（US）
Ampak Company, Inc.（US）
Arnet Pharmaceutical（US）
Swanson Health Products（US）
AIDP, Inc.（US）
Ortho Molecular Products（US）
Evesa Nutritionals（India）

简介目录

Product Code: SQMIG35I2355

Vitamin K2 Market size was valued at USD 184.22 Million in 2024 and is poised to grow from USD 209.83 Million in 2025 to USD 594.37 Million by 2033, growing at a CAGR of 13.9% during the forecast period (2026-2033).

The vitamin K2 market is poised for significant growth driven by heightened consumer awareness of its health benefits, demographic trends such as an aging population, and a growing interest in functional foods. Recognized for its positive impacts on cardiovascular and bone health, the demand for vitamin K2 supplements is increasing as consumers prioritize prevention of chronic illnesses and overall well-being. Research continues to underline its therapeutic potential, further fueling interest. Additionally, the rise in health concerns, notably osteoporosis and cardiovascular issues, emphasizes the necessity for effective vitamin K2 products. This essential nutrient aids in directing calcium to bones, thereby lowering fracture risk, and has shown promise in reducing cardiac issues and arterial calcification, contributing to a growing market presence.

Top-down and bottom-up approaches were used to estimate and validate the size of the Vitamin K2 market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Vitamin K2 Market Segments Analysis

Global Vitamin K2 Market is segmented by Function, Product Type, Form, Source, Application, and region. Based on Function, the market is segmented into Bone and Cardiovascular Health, Blood Health and Clotting, and Anti-Inflammatory and Immunity, Other Functions. Based on Product Type, the market is segmented into MK-4, and MK-7. Based on Form, the market is segmented into Capsules &Tablets, Powder and Crystalline, Liquids, and Others. Based on Source, the market is segmented into Natural, and Synthetic. Based on Application, the market is segmented into Pharmaceuticals, Functional Foods and Beverages, Health Supplements. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Vitamin K2 Market

The Vitamin K2 market has experienced substantial growth as individuals become increasingly aware of the importance of maintaining bone health. Enhanced public health initiatives and extensive media coverage have highlighted the role of Vitamin K2 in bone mineralization and osteoporosis prevention, thereby capturing the interest of consumers. This heightened awareness has led to a notable increase in demand as people seek to maintain strong bones and reduce their risk of fractures. The focus on educating the public about the benefits of Vitamin K2 in promoting bone density has fostered a proactive approach among consumers, significantly contributing to the market's expansion.

Restraints in the Vitamin K2 Market

The Vitamin K2 market faces significant challenges due to the high costs associated with premium supplements. Many high-quality options, particularly those incorporating bioavailable forms like MK-7, come with a steep price tag, making them less accessible to cost-sensitive consumers. This financial barrier may lead potential customers to either forgo Vitamin K2 supplementation altogether or opt for lower-priced alternatives that may not offer the same efficacy. Consequently, this reluctance to invest in quality products hinders broader acceptance and usage of Vitamin K2, ultimately limiting the overall growth potential of the market in a increasingly health-conscious landscape.

Market Trends of the Vitamin K2 Market

The vitamin K2 market is experiencing significant growth, driven by the rising consumer interest in functional foods that extend beyond basic nutrition to offer enhanced health benefits. As health-conscious individuals seek out products that contribute positively to their well-being, manufacturers are increasingly incorporating vitamin K2 into a diverse array of offerings, including plant-based alternatives, fortified dairy items, and nutritious snack bars. This trend reflects a broader wellness movement, with consumers actively pursuing ingredients that support overall health, thus expanding the market for vitamin K2. As a result, the availability of vitamin K2-enriched products is set to increase, attracting a wider customer base seeking enhanced nutritional options.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Case Study Analysis
Regulatory Landscape
Patent Analysis
Pricing Analysis
Technology Analysis
Trade Analysis
Customer & Buying Criteria Analysis

Vitamin K2 Market by Function

Market Overview
Bone And Cardiovascular Health
Blood Health And Clotting
Anti-Inflammatory And Immunity
Other Functions

Vitamin K2 Market by Product Type

Market Overview
MK-4
MK-7

Vitamin K2 Market by Form

Market Overview
Capsules And Tablets
Powder And Crystalline
Liquids
Others

Vitamin K2 Market by Source

Market Overview
Natural
Synthetic

Vitamin K2 Market by Application

Market Overview
Pharmaceuticals
Functional Foods and Beverages
Health Supplements

Vitamin K2 Market Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2025

Key Company Profiles

AlloSource (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smith + Nephew (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Orthofix US LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zimmer Biomet (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Geistlich Pharma AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biobank (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DSM Nutritional Products (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pharmavit (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Viridis BioPharma Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lactonova Nutripharm Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gencor Pacific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NuScience Trading, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NutriScience Innovations LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ExcelVite Sdn. Bhd. (Malaysia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Parchem Fine & Specialty Chemicals (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Avanscure Lifesciences Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Health Thru Nutrition (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ampak Company, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Arnet Pharmaceutical (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Swanson Health Products (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AIDP, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ortho Molecular Products (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Evesa Nutritionals (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments